The present study was a multi-stage integrated study designed and developed using the guidelines of other countries and the viewpoints of the expert group in accordance with Iranian culture and religion. The clinical guideline for MMB was prepared with the modeling of the NICE model and other databases that are closer to the research subject [19]. The study was conducted in three steps:
The First Step: Advanced Text Review
The first stage of the study was done to determine the contents of MMB clinical guidelines. The inclusion criteria were valid sites and the papers published from 2000 to 2018. Priority was given to the papers written in the field of the clinical guideline of MMB or the ones developed through a systematic review or meta-analysis. The Papers whose full text was not available or were unrelated to the subject were excluded.
The research environment was all global sites, libraries, and electronic resources. The population under study was papers, clinical guidelines, and related scientific books to the subject obtained through advanced searches of texts. To access to the global clinical guidelines and papers on MMBs, the relevant keywords based on (Table 1) were used to probe. The papers that met the inclusion criteria were selected using non-probability and convenience sampling methods. These papers constituted the sample size. Finally, 1235 papers and guidelines were included in the study. In this step, the draft of the clinical guideline was prepared.
Table 1: Combination of keywords in systematic research
Key Word and Combination
|
|
Guideline
Protocol
Pathway
|
AND
|
Mother milk bank
Breast milk bank
Human milk bank
Donor milk bank
|
Milk banking
Mother milk banking
Human milk banking
|
|
|
|
|
|
The Second step: Determining the Expert Group Agreement
The second stage was designed for determining the degree of agreement of the expert group on the components and the content of the clinical guideline draft. The prepared draft was sent to 30 specialists (according to the Neonatal Health Department) across the country. Their corrective comments were then applied according to (Table 2) in the above guideline.
When a care guideline is prepared, this guideline should be reviewed by representatives from different disciplines. The viewpoints of knowledgeable people should also be taken into account for developing the guideline because they may identify issues not mentioned in the text review and need evaluation [19].
Table 2: Discussed items in the focus group
|
The specified items for discussion in the focus group
|
The focus group’s Comments and suggestions on the item (the reasons for discussion)
|
The discussion result (rejection or acceptance of the discussion)
|
1
|
The clinical guideline of mother milk bank
|
Change to the clinical guideline of mothers’ milk bank
|
Rejection
|
2
|
Treating the donated milk
|
Preparing the donated milk
|
Acceptance
|
3
|
Help the high-risk infants requiring breast milk to live longer
|
Improve the high-risk infant health and improve their early prognosis
|
Acceptance
|
4
|
Guideline realm (in Neonatal Intensive Care Units(NICU))
|
Clinical guideline real ( in hospitals and healthcare centers having Neonatal center and NICU)
|
Acceptance
|
5
|
Clinical guideline users (top managers)
|
Clinical guideline users (head and managers of hospital)
|
Acceptance
|
6
|
Clinical guideline users (pediatricians, sub-specialist of neonates)
|
Clinical guideline users (pediatricians, sub-specialist of neonates, gynecologists, nutritionists, clinical biochemistry
|
Acceptance
|
7
|
Clinical staff and healthcare team
|
Nursing and assistance personnel, laboratory experts, other staff working In the hospital
|
Acceptance (nurses of the neonatal unit, midwife, and other staff at the health centers
|
8
|
Supportive staffs of breast milk donors
|
Other administrative and service personnel attracting breast milk donors
|
Rejection
|
9
|
Community health practitioner (family physician)
|
General practitioner (family physician)
|
Acceptance
|
10
|
Treating the donated milk
|
Transferring and preparing the donated milk
|
Acceptance (preparing the donated milk)
|
11
|
The religion issue specific to our country
|
Executive priority
|
Acceptance
|
12
|
The issue of religion
|
Low priority and feasibility due to contradiction with different religions
|
Acceptance provided that the religion issue will be clarified
|
13
|
The lactation consultant
|
Lactation consultant in mother milk clinic
|
Acceptance
|
14
|
Pasteurizing the preserver
|
Pasteurizing the holder
|
Acceptance
|
15
|
Quick freezing of the milk
|
Quick cooling of the milk
|
Acceptance
|
16
|
Pumping the breast milk
|
Breast pump
|
Acceptance
|
17
|
Is it necessary to mention to the demerits of using an electric breast pump
|
Low priority (is it necessary?)
|
Acceptance (it is better to be mentioned)
|
18
|
Estimating the cost of setting up the milk bank
|
Low priority
|
Rejection
|
19
|
Alcohol drinking of the donor
|
Low priority (no alcohol drinking)
|
Rejection
|
20
|
Visiting the donor home
|
It is possible?
|
Acceptance
|
In this step, the research environment included the universities of Medical Sciences in Isfahan, Tabriz, Mashhad, Shiraz and the Neonatal Health Department in the Ministry of Health and Medical Education. The population under study was the faculty members of the above institutions and universities. The inclusion criterion was having expertise in the field of breast milk tailored to the content of clinical guidelines (sub-specialist of neonates, a specialist in religious affairs of breast milk, nurses with bachelor and master degrees). The exclusion criterion was the reluctance to cooperate in the study. As the researchers were looking for the people whose specialist knowledge was breast milk, the sampling was therefore purposive at this stage. Those specialists who were participating in this stage formed the sample size. Since the clinical guideline was sent to 30 people and only 25 people submitted their corrective comments, the final sample size included 25 people.
The Third Step: Determining the Quality and Utility of the MMB Guideline
The third stage was done to determine the quality and utility of the prepared guideline. The AGREE questionnaire was used to reach the above goal. The AGREE tool is a generic tool that is designed to provide a framework for evaluating the quality of clinical guidelines, whereby one can assess the clinical guideline. The quality of clinical guidelines indicates that every possible bias is avoided in the process of developing guidelines, the internal and external validity of the recommendations is provided, and the recommendations can be implemented in the clinic. This means considering the advantages, disadvantages, costs of the recommendation as well as the practical aspects of implementing recommendations. The AGREE tool evaluates the quality of content presentation and some aspects of recommendations and examines the success likelihood of the clinical guideline in reaching the desired behavioral consequences (predictive validity of the guideline) [20]. In this stage, the research environment was Isfahan University of Medical Sciences, Isfahan Islamic Azad University (Khorasgan), and Amin and Alzahra hospitals. The research population was the employed faculty members and nurses in the above hospitals. The inclusion criterion was having expertise regarding the breast milk and the exclusion criterion was the reluctance to cooperate in the study. The researchers were looking for people with expertise in breast milk, so the sampling at this stage was purposive. The number of participants at this stage constituted the sample size. As the clinical guideline was sent to 20 people and just 10 returned their corrective comments, the sample size was equal to 10. The results were then analyzed by SPSS20 utilizing descriptive statistics.